FDA Expands Palynziq to Adolescents

Palynziq (pegvaliase-pqpz) is a prescription enzyme treatment for phenylketonuria (PKU), a genetic condition that causes a buildup of phenylalanine (Phe) in your blood. This medicine provides an enzyme that stands in for the one your… Read more

Sogroya: Once-Weekly, Long-Acting Shot for Adults With Growth Hormone Deficiency and Children With Short Stature (GHD, SGA, Noonan Syndrome, ISS)

Sogroya (somapacitan-beco) is a long-acting form of human growth hormone. You take it as a shot under the skin (subcutaneous) one time each week. It attaches to growth hormone receptors and triggers effects in the… Read more

Bysanti: FDA Approves New Atypical Antipsychotic Pill for Adults with Schizophrenia or Manic/Mixed Episodes in Bipolar I Disorder

Bysanti (milsaperidone) is a new FDA-approved oral medicine for treating certain mental health conditions in adults. It belongs to a group of medicines called atypical antipsychotics and is approved for the treatment of schizophrenia, as… Read more

Yuviwel (Navepegritide): Once-Weekly Shot to Help With Growth in Children With Achondroplasia

Yuviwel (navepegritide) is a once-weekly shot for children 2 and older with achondroplasia who still have open growth plates. It is approved by the FDA to help increase height in this group. Yuviwel is a… Read more

Dupixent: FDA Approves First and Only Medicine for Allergic Fungal Rhinosinusitis in Adults and Children Ages 6 Years and Older

Dupixent (dupilumab) is a prescription medicine for treating various allergic conditions and is given as a shot under the skin. The FDA has now approved Dupixent for treating adults and children (ages 6 years and… Read more

Keytruda With Paclitaxel: FDA Approves New Combination Therapy for Certain Cancers Affecting the Ovaries, Fallopian Tubes, or Peritoneum

The FDA has approved a new combination therapy for adults with epithelial cancers that start in the ovaries, fallopian tubes, or lining of the abdomen (peritoneum). This treatment is meant for patients whose cancers express… Read more

Hernexeos: FDA Approves First-Line Use for Certain Advanced Non-Small-Cell Lung Cancers With HER2 Mutations

Hernexeos (zongertinib) is a prescription medicine known as a kinase inhibitor that is used for treating adults with advanced non-small-cell lung cancer (NSCLC) that cannot be removed surgically or has spread to other parts of… Read more

FDA Approves Rybrevant Faspro: A Time-Saving Under-the-Skin Injection for Use in Combination With Lazcluze for EGFR-Mutated Lung Cancer

Rybrevant Faspro is a new under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has now approved it in combination with another medicine called Lazcluze (lazertinib) as a first-line treatment for… Read more

Adquey: FDA Approves New Nonsteroidal Ointment for Mild to Moderate Eczema

Adquey (difamilast 1%) is a prescription ointment the FDA has approved for adults and for children 2 and older who have mild to moderate atopic dermatitis (AD), often called eczema. It is a nonsteroidal medicine… Read more

Yuvezzi: First Combination Eye Drop for Age-Related Near Vision Loss

Yuvezzi is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you age. It’s the only FDA-approved eye drop that combines two… Read more